| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.008 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.093 | 0.009 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.009 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.01 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.097 | 0.01 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.18 | 0.01 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | 0.086 | 0.01 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.01 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.095 | 0.01 |